24 min read

Webinar Recording: Documentation That Survives an ADR

Webinar Recording: Documentation That Survives an ADR

Your team can make every right decision for a patient and still struggle to prove it five months later. When an ADR arrives, the reviewer was never at the bedside. All they have is the record, and it has to explain what happened and why.

In this webinar, Jamie Kuelker, RN, BSN, MBA, Client Success Manager at QAPIplus, joins Sara Nigro, VP of Sales at BetterRX, to trace one hospice medication from the moment it's ordered to the moment an ADR asks about it. Together they show where the operational record and the clinical record support each other, where the gaps tend to show up, and how to build documentation that stands on its own.

In This Recording, You'll Learn:

  • What an ADR is, why hospices get them, and what's at stake when a response misses the 45-day window
  • Why the answer to a medication ADR lives in two places, the operational record and the clinical record, and where the gaps between them form
  • How one medication decision should connect from reassessment to goals of care to an updated plan of care, using a fictional patient as the example
  • The questions a reviewer is really asking, and a five-step sequence for building a response they can follow without guessing
  • How to turn every ADR into a QAPI data point with a find, measure, fix, and re-audit loop
  • Where to start this quarter, plus Q&A on using AI tools like ChatGPT without putting PHI at risk


WEBINAR TRANSCRIPT:

Sara Nigro · 0:03

Hi, everybody. We're just giving everyone a second to join. Thanks for taking some time with us. While we wait, feel free to jump in the chat with your Thanksgiving side this year, if you're making one. I'm very curious, because I want to spice up what I'm making for Thanksgiving. I've got my mom coming into town. So I'd love to know in the chat if you're planning to cook anything, and what that's going to be this year.

Jamie Kuelker · 0:38

That's a good suggestion. Are you famous for anything at Thanksgiving, Sara?

Sara Nigro · 0:42

I don't think so. We did make some carrots one year that everybody wants now. But I don't want to be known for carrots.

Jamie Kuelker · 0:52

It's not the razzle dazzle.

Sara Nigro · 0:54

No, it doesn't, but it's practical.

Jamie Kuelker · 0:58

Yes, it is.

Sara Nigro · 0:59

But yeah, if you have a side that you're making for Thanksgiving, or a main, throw it in the chat. We've got no takers. Everybody's shy.

Jamie Kuelker · 1:13

It looks like the chat is turned off for this one.

Sara Nigro · 1:16

Oh, good. Never mind.

Jamie Kuelker · 1:20

They're trying, I'm sure.

Sara Nigro · 1:26

I'm like, nobody wants to tell us what they're making for Thanksgiving. That's weird.

Jamie Kuelker · 1:30

Well, it might be for the better, Sara. We'd be turning this webinar into a recipe-sharing session.

Sara Nigro · 1:35

Yes, a cookbook follow-up.

Jamie Kuelker · 1:38

That's right.

Sara Nigro · 1:40

The BetterRX cookbook, coming soon.

Jamie Kuelker · 1:43

Cooking with QAPIplus.

Sara Nigro · 1:45

That's right. I like that. I like that.

Well, before we get started, I just want to thank everybody for joining us. I'm Sara Nigro, VP of Sales at BetterRX, and I'm really excited to be joined today by Jamie Kuelker. Did I say it right? I think I botched it.

Jamie Kuelker · 2:07

Kuelker. That's okay. That's all right.

Sara Nigro · 2:09

I'm sorry. I dropped the wrong letter.

Jamie Kuelker · 2:14

That's okay.

Sara Nigro · 2:14

I think anybody who's worked in hospice knows that your team can make all of the right decisions for a patient and still have a really hard time proving that story months later. So today we're planning to talk about what happens when an ADR comes in and the person reviewing the record wasn't involved in that patient's care. Can they actually follow what happened and understand why it happened?

We're going to make this really practical and walk you through what that documentation looks like. We're following one patient, one medication, and the decisions and workflows that go along with it. We'll show where the operational record and the clinical record support each other, and where the gaps tend to show up.

The chat is deactivated for this webinar, but we're going to leave about 10 to 15 minutes at the end for Q&A. So feel free to add anything to the Q&A tab, and we'll address it at the end.

Jamie, we're so grateful for your time today and your expertise. At this point, I'm going to tell you a little more about who you have in front of you today.

So, a little context on both of us. I'm Sara, and I lead sales at BetterRX. A huge part of my job is sitting with hospice leaders and their teams and understanding what actually happens between the moment a medication decision is made and the moment the patient receives that drug. We're a technology-first pharmacy and medication management partner to hospice agencies. Our team spends a lot of time thinking about the ordering process, from coverage decisions to pharmacy fulfillment, and whether people can actually see what happens along the way.

Joining me today is Jamie, who brings the clinical and quality perspective that truly makes this conversation complete. She's an RN with a BSN and an MBA, and she has more than 18 years of leadership experience spanning acute care, virtual care, population health, healthcare technology, and enterprise strategy. Jamie is also a Client Success Manager at QAPIplus.

What I love about having her here today is that we're coming at the same problem from two different directions. I see the operational workflow and the medication workflow. Jamie is the clinical documentation arm, the compliance requirement. Coupling those together, I think we're going to be able to tell you a very complete patient story that's accurate and based on real-world expertise.

So, Jamie, thanks again for joining me. Feel free to chime in and tell everybody a little about what you do and what your role is at Better... sorry, at QAPIplus.

Jamie Kuelker · 5:24

Thanks, Sara. As Sara described, I worked as a registered nurse and have worked extensively in the leadership space as well. Today I spend my days with hospice and home health teams, focusing on their quality programs. That can include things like incident reports, chart audits, their QAPI program, survey readiness, and more.

The question we're tackling today is one I care deeply about: does the record tell the whole story? Those of you who review documentation know that sometimes we look at a chart and we're only getting little tidbits of what actually took place. So the focus of our conversation today is what those findings can look like. Can they stand on their own? And is the clinician really painting that clinical picture for the documentation reviewer?

Thanks, Sara.

Sara Nigro · 6:22

Absolutely. Thank you.

Before we jump into our example, we thought it would be smart to level-set on what an ADR actually is. Whether you're newer to hospice or a legacy hospice provider, we want to make sure it doesn't sound like just another administrative request.

ADR stands for Additional Documentation Request. Pretty brass tacks there. This is a request coming from a Medicare contractor, asking you to produce supporting records for a claim that's already been submitted. That could be five months from now, or it could be pretty immediate.

As our slide outlines, there's a 45-day response window, and missing that deadline can mean a denial. It doesn't work to say, "We've been trying to submit it, we're past the 45 days, but here it is." No. Forty-five days is a pretty hard cutoff.

These requests can come from targeted reviews, from routine sampling, or because your data looks a little unusual. The impact on your team isn't just the time it takes to pull these documents together. It's the potential for payment delays, denials, recoupments, and sometimes Medicare getting a little more into the weeds with your business. We all know Medicare is pretty deep into hospice right now. So you want to be proactive and ahead of the game, so they're not coming after you when it's unnecessary.

I think the most important thing going into an ADR is that the reviewer wasn't there. They don't know your nurses, they don't know your patient, and they don't know what conversations happened at the bedside when you made these decisions. All they have to go off of is what your team documented.

You might have made a completely appropriate decision. You saw a need, you reacted in real time, and you did the right thing for your patient. But if the record doesn't explain it, you're asking somebody to connect dots they really shouldn't have to connect, and that might also be really hard to pull from memory.

That's really the theme today. It's not about the complications of an ADR or the repercussions of it. It's about understanding the what and the why that go into it.

From the BetterRX side, the operational record can show what was ordered, who placed it, when it was covered, why it was covered, what it was designated as, and how it moved through the pharmacy process. But that doesn't by itself tell you why the team made that clinical decision. That's where QAPIplus's expertise comes in. Jamie, I don't know if you want to share anything on how our two perspectives line up and give you a stronger story.

Jamie Kuelker · 9:32

Yeah, absolutely. That's where QAPIplus can come in. We have a self-auditing process, and we have an AI clinical chart auditing process, where we're double-checking: do all of those documentation elements exist? Are we in compliance, so we can avoid that ADR? It's a proactive approach.

Just as Sara described, you may have done everything right. A lot of us as registered nurses and other care team providers are doing the right thing by the patient. We're providing excellent care. But with the documentation requirements, we're held to that standard, and we need to make sure all of those elements are in place to optimize our reimbursement and avoid these ADRs.

Thanks, Sara.

Sara Nigro · 10:19

Yeah, absolutely. Thank you.

I think this slide is really useful because it gets into the issue we're both hearing over and over again from hospice agencies across the country. It's not that the information is missing. It's that it's living in different places.

On one side, you have the operational record. That includes who ordered the medication, the coverage designation, when it was ordered, and the actual pharmacy and delivery activity. On the other side, you have the clinical record: what changed for the patient, what the IDG decided to do, and what that reasoning was.

So the information is there. It's just living in two different places. In a perfect world, those records tell the exact same story. In the real world, somebody might be jumping between an EMR, a pharmacy portal, IDG notes, and previous billing records, trying to piece together a decision from months ago.

The problem isn't just the administrative work of chasing your tails to get all of that information buttoned up. It's that every single manual handoff creates an opportunity for a gap or an inconsistency. That's why our theme today is getting your information together from the jump, so you're not having to be so reactive. And it's why we care so much about making medication decisions visible at the point of ordering, so you're not reconstructing them after the fact.

Before we show you what this looks like, I'm curious how everybody's handling this today. We're asking you to make this a little interactive for Jamie and me, because we suspect there's a pretty wide range of answers. We're not recording any names. This is completely confidential.

Is a rationale documented for every change? Is it well documented at admission but not consistently revisited? Does it depend on the clinician or the location? Or would somebody have to go digging to find the answer? If you don't mind taking 20 or 30 seconds to tell us where you are today, that will help us understand where your operational and clinical pieces begin to separate.

Jamie, are you seeing the poll up on the slide?

Jamie Kuelker · 13:03

Yes, ma'am, I am.

Sara Nigro · 13:04

Okay. We'll give it a couple of seconds.

Jamie, are you seeing anything?

Jamie Kuelker · 13:44

I am not. I dismissed my own submission because I wanted to let the audience participate, but I don't see any results populating.

Sara Nigro · 13:57

That's okay. We'll keep moving.

If you're answering off the top of your head: if your answer was A, that would be great to see. The real test is whether you could pull that same rationale and connect it to the same order several months later.

If your answer was B, I agree, that can make sense too. Admission gives you a natural checkpoint. The hardest part is probably catching the moments when the patient's condition changes.

And if you're mostly answering C or D, this is exactly the kind of variation that makes an ADR so time-consuming. It doesn't mean the care wasn't good. It means the evidence is harder to assemble. If the results are mixed, we're okay with that too. There's always an opportunity for improvement. Thanks for at least answering in your head. We couldn't see your answers in the poll.

Jamie Kuelker · 15:01

Sara, I did find them. I did find them.

Sara Nigro · 15:03

Yes.

Jamie Kuelker · 15:05

It was pretty neck and neck, but the majority said it varies by clinician or location. A close second was that a rationale is documented for every change.

Sara Nigro · 15:17

Okay. I'd say A is our winner for defending against an ADR, but we'll take mixed. If it's C, that variation will just make your ADR response a little more time-consuming. But again, it doesn't mean there was a lapse in care.

Thanks, Jamie.

Jamie Kuelker · 15:38

Yeah, absolutely.

Looking at this slide, what I love about walking through it this way is that it mirrors exactly how an ADR unfolds. The order happens in real time. The question shows up months later. Steps one and two are where the evidence gets created. Steps four and five are what you do with it: answer the reviewer, and make sure the next record is stronger. That last step, highlighted here, is the one most organizations skip.

We can go to the next slide, please.

Sara Nigro · 16:17

Yes, ma'am.

Jamie Kuelker · 16:18

Awesome. So we have a patient as an example here. I want to make a quick note for the audience: Mrs. Ellis is a fictional character. She is not a real patient. But if you look at her primary and secondary diagnoses, I'm sure you can think of a few Mrs. Ellises you've encountered in your career, as I have. And nothing I'm stating today is clinical guidance. She's here to show us what a defensible trail looks like.

As I said, Mrs. Ellis is a very real-life scenario. A patient presents one way on day one. The disease progresses, and her needs change along with it.

On day one, the IDG looked at her furosemide and said it's unrelated to her terminal diagnosis, which is listed here as end-stage COPD. And they documented the why. That was the first decision, done correctly.

But on day 23, things have changed. Her swelling and shortness of breath have progressively gotten worse. The team reassessed, made a new decision, and documented that as well. So five months later, when the ADR asks about furosemide, ideally nobody is scrambling, because we have defensible documentation. The answer is already in the record.

The lesson here is that the documentation has to reflect where the patient is now, not where she was on admission. And it also needs to tie back to her goals. Mrs. Ellis's goals are simple: comfort at home.

Sara, I'd love to hear more of your thoughts on deprescribing, because I know you talk about it often. When a patient comes onto hospice, every med gets a fresh look. Is it comfort-focused, or is it aimed at slowing the disease? Can she still take it the way it's prescribed? And that review doesn't seem like a one-time event. Can you tell us a little more?

Sara Nigro · 18:24

Yeah, and I appreciate that. She's 84, and end-stage COPD is her terminal diagnosis. Her goal of comfort has changed things, as you mentioned early on. When she's admitted to hospice, we're not trying to treat her for the same symptoms in the same way we did before she was considered terminal.

Knowing that the goals have changed, working with the family and leading with empathy is where we ask clinicians to start. Admission is your best opportunity to say, "We're honoring the history of why these medications were prescribed. It doesn't mean anybody was wrong. It just means our goals are different today." We're looking at what good looks like today and what our treatment plan is. Reassessing that should be your main priority at the time of admission. That's the easiest opportunity to have those conversations with a family member.

Remember to make sure the drug still fits the way the patient can take medication. If they're having trouble swallowing or can't keep a medication down, look at other ways of receiving that drug. That all starts at that first admission moment, and you should consider it when you're deprescribing too. What value is this going to bring the patient if they can't even keep it down?

That's our best bet for deprescribing, and you keep assessing throughout their care. On day 23, you've documented why the decision was made to reassess their medications. Maybe it is deprescribing. Maybe they wanted to keep a vitamin, and you're finally getting them to take a step back from some of those non-essential medications. But it's always about reading the patient and making it about their goals for comfort and care at the end of life.

Jamie Kuelker · 20:28

That's fantastic. Thanks.

Sara Nigro · 20:32

Sorry, I jumped ahead. That was me. That was me. I got clicker happy. Okay, are you ready?

Jamie Kuelker · 20:38

I am. I am.

All right, everyone, this is a slide I'd love to put on every hospice team's walls. Four steps, and each one points to the next.

First, reassess. The RN documents what has changed: the worsening swelling and the increased shortness of breath. This is specific, and it's observable.

Next, goals of care. Mrs. Ellis wants to stay comfortable at home. That's the lens for every decision that follows.

Then, decide. The physician and the IDG agree that furosemide is now related and covered, and the dose is adjusted. Furosemide is a great example of that gray zone. You really need supportive documentation that shows it's being prescribed for comfort, not to prevent or stall disease progression.

Then we have the documentation itself. The plan of care, the addendum, and the med profile all need to be updated.

A reviewer should be able to follow that chain without calling anyone. If they have to pause, question, or guess, that's where the gap is. So when you're self-reviewing or auditing your documentation, put yourself in that position. You've never seen the patient. You've never witnessed any of the care. Can you put these pieces together and fully understand what took place?

Sara Nigro · 22:15

Absolutely. Jamie, thank you for walking us through what that looks like for the clinical team when it decides to make a change.

Now I want to dive into what happens operationally when that decision becomes a medication order. On this screen, we're about to walk through the prescription process and medication ordering for Mrs. Ellis.

This is something I'm particularly passionate about, because I've seen so much downstream confusion start when the coverage decision isn't clearly tied to the prescription going out. What we always prompt in our system is: Is this medication hospice-covered? Was it considered related or unrelated to the diagnosis at the time of the order? Did something change as the patient progressed? And how can your team show that the designation was made when the order was placed?

In the BetterRX workflow, and this is an illustrative image, we assign coverage as a designation at the beginning, when the order itself is placed. This really matters, because you don't want to rely on a separate spreadsheet, somebody's memory, or an email thread months later to explain why and how a medication was classified. Everything is teed up in the system.

For Mrs. Ellis, this dose change was to 40 milligrams. The order was entered on day 23 at 2:14 by the hospice nurse, and the attending physician was identified as the prescriber. Following the clinical team's review, the order is marked as covered.

The key distinction is that the system does not decide the clinical rationale for your team. We still want the clinical team making that decision. What we want is for the operational record to faithfully reflect it at the point the order is placed. If an ADR arrives, and we keep saying five months later, there's a meaningful difference between being able to show that history and having to explain what you think probably happened.

Once we've placed this order, the second question is what happens to the medication afterward. This is where the operational side becomes very valuable, because ordering a medication and getting it to the patient are not the same thing. We've all likely experienced it in hospice: the calls from nurses and families start when somebody's waiting on a prescription. Has the pharmacy received it? Is it being filled? Is it out for delivery? Where can the nurse go to find that information? Who's responsible for relaying it? When the team doesn't have that visibility, the nurse often becomes the person chasing answers and fielding questions they can't answer.

So we're very proactive about showing what this workflow looks like. For Mrs. Ellis, the order was created at 2:14, approved at 2:31, sent to the pharmacy at 2:32, received by the pharmacy at 2:40, out for delivery by 5:05, and delivered by 6:48. You don't have to memorize these timestamps. What matters is that there's a sequence your team can follow.

From an ordering and operations perspective, that visibility helps answer questions in the moment. Who's got the drug? Where is it? From an ADR perspective, it gives your team historical evidence of what happened, without having to reconstruct it from calls and emails.

I'd love for everybody on the call to think about this. If somebody asked you for the complete history of one medication order from five months ago, how quickly could you put it together if you're not using a system like BetterRX today? Just think about what that process looks like for your team.

For me, the takeaway on this slide isn't just that the medication arrived the same day in this example. It's that the record can show you the path it took to get there. Visibility is king.

I want to spend a little time on this next slide, because I think it's important to be clear about what technology can and cannot do. Our team is incredibly focused on giving hospices a clear operational record. We can help establish what was ordered, when it was ordered, who placed it, and what happened through the pharmacy process. But it's not the entire clinical story. So I'd love to pass it over to you, Jamie, to speak more about the compliance record.

Jamie Kuelker · 27:34

Yeah, absolutely. I'll be really honest: I think this is one of the most important slides we're showing you today.

Everything Sara has shown is strong evidence. It proves what happened: what was ordered, when, and by whom, the coverage status at each order, and the path through the pharmacy. But it doesn't necessarily prove why. And the why is what the reviewer is really evaluating.

The why lives in the compliance record. This is where the clinical rationale really shines: the prescriber and IDG agreement, and the day 23 reassessment. A pharmacy record cannot document clinical judgment. Only your team can.

So one record proves what happened. The other proves why. You need both, and they both need to tell the same story.

Sara Nigro · 28:27

Absolutely. What I think complements this slide so well is that we're taking both the BetterRX perspective and the QAPIplus perspective, the accurate order record of what happened alongside the clear story of why it took place, in one fell swoop, so your team isn't chasing information.

Jamie Kuelker · 28:52

Absolutely. So this is where, sorry. This is where I'd love for the group to put yourselves in the reviewer's seat, as I said before. I bet most of you have seen every single one of these. Sara, what about you?

Sara Nigro · 29:13

I like this because it makes the ADR feel a little less abstract. The reviewer isn't just asking whether you have documents. They're trying to understand whether the documents support the care and the claim. So for me, it makes a lot of sense. Was the medication actually ordered? Who ordered it? I think this is pretty important as well.

Jamie Kuelker · 29:42

Absolutely. And the clinical question here is the rationale. It's not just what you did, but why it made sense in the moment for this patient at this point in their illness.

The hardest questions are the ones that need both records. When the symptoms changed, was the decision revisited? To answer that, you need the reassessment from the clinical record and the order change from the operational record, and the times need to line up. So make sure your plan of care, the addendum, and the billing all agree. If one says not covered and the other says covered, the reviewer is going to notice.

I think we want to go to the next one here. Sara, that's me.

Sara Nigro · 30:33

Darn it. I'm sorry.

Jamie Kuelker · 30:35

No, you're good.

Sara Nigro · 30:36

Guys, I'm clicker happy. Forgive me.

Jamie Kuelker · 30:39

We'll battle it out.

So on this slide, the ADR lands. How do you build a response that's going to hold up? Is it going to have legs? The goal isn't more paper. That's not what anyone is asking for. It's a trail the reviewer can follow without guessing. We're basically teleporting the reviewer into the patient care experience, as if they were there.

One, pull both records: the order history and the clinical record, side by side. Don't send one and just hope for the best.

The next column: build one timeline. The orders, the visits, and the IDG notes, in order. This is where the gaps are really going to pop out.

Third, match the rationale. At every decision point, find the reasoning. If a med changed, where is the why?

Then we check for consistency. Plan of care, addendum, med profile, billing: every document tells one seamless story.

And finally, write the narrative, a short summary that walks the reviewer through it. We say it all the time in the clinical space: we're painting a clinical picture. I think of Bob Ross painting happy little trees. We're illustrating what happened so it's almost as if the reviewer were there themselves. This is going to make your job easier, which makes it easier for the reviewer to say yes.

So this is a sequence. It's not a checklist. Each step builds on the ones before.

One thing I want to add before we move on: we don't want step three to be the first time anyone checks for the rationale. Medicine has historically been a very reactive world, and we want to move toward being more proactive. That's where the QAPIplus clinical chart audit can really shine and help alleviate some of the retrospective correction a lot of people are doing five months down the road, as Sara described.

You can check that these documentation elements are there before the claim goes out, and get feedback to the clinician in as close to real time as possible, while it's still fresh. As a clinician myself, seeing many, many patients and being very busy, if you asked me five months from now about the rationale for a specific medication change, it would be very difficult for me to be truthful and accurate about what took place.

If a denial does come through, you can audit that chart again. It's a very simple process. You can find the gaps, know exactly what you're addressing, and get the documentation as compliant as possible before you submit for billing.

Sara Nigro · 33:48

Absolutely. One thing about this slide: if anybody's going to take a screenshot, this is the one, because, like you said, it's a sequence and not a checklist. Do this in order, and you'll be set. I think this one is imperative.

Jamie Kuelker · 34:08

I agree.

Sara Nigro · 34:11

So, looking at Mrs. Ellis's story in one place, to me this is what good documentation should make possible. You don't have to guess the sequence or fill in the gaps with an explanation after the fact.

On day one, the team documents the clinical rationale for considering the drug unrelated, and the medication profile reflects a non-covered designation. So check that those two places line up.

Skipping to day 23 and that meaningful clinical change: the RN's assessment is documented at 1:50. The physician and IDG determine at 2:05 that the medication is related. At 2:14, the order is entered with its new coverage designation, and the medication is delivered later that evening. The plan of care and the addendum are shown as updated on day 24.

What I notice in this order of events is that the clinical reassessment and decision come first, and the ordering and fulfillment record then reflect that decision. If someone comes back months later asking why that coverage changed, here's your traceable explanation and a collection of timestamps.

That's the bigger win for us here. We're not simply documenting activity. We're documenting the clinical decisions that went into that operational execution, so the patient's story makes sense from start to finish.

So, Jamie, once we're finding these kinds of gaps and you've confirmed that's happening, how do we turn this into something an organization can improve over time?

Jamie Kuelker · 35:58

That's where the audits come in. You can provide real-time feedback to your clinicians or your QA team to make the corrections. Those conversations are teachable moments as well. That's where one-on-one coaching comes in, and having tangible evidence to show your clinicians makes the coaching much more actionable for them.

Consistency is what's important. Having a process in place is what keeps this engine moving forward and reduces ADRs for your team overall. So it's two different workflows, but one single loop we're trying to close here.

Sara Nigro · 36:41

Absolutely.

Jamie Kuelker · 36:45

On this slide, I want to get us back into the mindset I mentioned earlier. We don't want to be reactive. We want to focus on prevention.

One ADR tells you about one chart. A pattern across ADRs, or across your own audits, tells you about your process. So every ADR is a QAPI data point.

Here's the loop. First, find: spot a pattern. For example, med changes without a documented reassessment.

Then measure. That's an audit you perform on a sample of charts to set your baseline. You don't have to audit every single chart. A consistent sample tells you where you stand.

Now we go to fix. This is your intervention, and it isn't always a dose change. It might be a therapeutic alternative, a coverage question, or a documentation gap. If the gap is reassessment documentation, the fix might be clinician education, as we just discussed, a template change, or a new trigger in your workflow. There are multiple potential solutions, but the process needs to be in place.

The fourth column, which I'll wrap this slide up with, is re-auditing. We sample again, the same way, consistently. Did the fix work? We repeat this every quarter. That's what turns this into a program instead of a one-time cleanup. It lets your team work with consistency and a clear understanding of expectations over a longer period of time, instead of putting out one fire and then moving on to the next fire.

Sara Nigro · 38:46

Love it. It's the truth.

Jamie Kuelker · 38:49

It is the hard truth.

Sara Nigro · 38:51

It is.

Jamie Kuelker · 38:52

All right. So this is where BetterRX is creating the data, and your QAPI program uses that data. As I said before, two different workflows, but one loop.

The QAPIplus tie-in is that the audit is where the data shows up. Your baseline, your findings, and your re-audit results all live in one centralized location. I don't know about you, but I've worked in plenty of places with Excel sheets here and there, things stored on SharePoint, binders here, papers there, file folders. It can get wild real quick. Here we have an opportunity to keep everything centrally located and organized, so you can adhere to that consistent process.

We want to be able to identify those gaps. Are we closing them without having to rebuild a spreadsheet every quarter? Is the fix bigger than a quick change? If it is, that's where we initiate a PIP.

Sara Nigro · 39:58

Thank you.

Jamie Kuelker · 39:59

You're welcome.

Sara Nigro · 40:02

I think we're probably ready to wrap up with something you can take back to your team, because we can talk about the process all day long, but the value comes from the changes made after this webinar.

I think the first habit is designating coverage when the medication is ordered. That's the operational practice that will create change for your team right away and give you a record you can return to later.

Jamie, do you want to chat through the documentation aspect?

Jamie Kuelker · 40:40

Sure, absolutely. The goal is always high-quality documentation. That's everybody's goal, of course. But it's really about getting the education out to your teams, because the requirements change often. I'm hoping some of you are smirking at that, because I am internally as well. The documentation requirements change often, and the reimbursement rates change as well.

Sara and I are both here representing companies that can support you along the way to optimize those processes and make them as painless as possible, for your team members and for you as leaders, as you educate your teams on executing documentation in a high-quality manner, and efficiently. Ultimately, that lets them focus on their goal, which is providing great care to all of our patients.

So we're here for you, and we have lots of resources. Sara, I don't know if there's anything else you want to share. I've really enjoyed the conversation today and being here with you.

Sara Nigro · 41:46

Me too. Thank you.

If there's one thing I'd encourage you to do this week or next week, knowing we're going into Thanksgiving, it's this: pick a patient, pick a medication, and see whether somebody who wasn't involved in the case can understand what happened and why. I think you'll learn a lot about the strength of your current process in a very short amount of time, without being exposed to an ADR. You're doing it internally before it becomes a problem you have to answer for.

So thank you again, Jamie. Your expertise is incredible, and it really helps us connect the story of the what and the why.

Now I'll open it up to questions. Jamie and I are happy to stay on and talk through any situations you might have, so feel free to chime in through the Q&A.

It looks like we have one here, and I'll read it aloud for everyone: "We usually find out about a documentation gap when the ADR shows up. Where should we start if we want to get ahead of it this quarter?"

Jamie Kuelker · 42:53

With ADRs, again, prevention is key. If you want to get ahead of it and you don't have software supporting your auditing processes, develop an auditing process: a high-quality audit that aligns with Medicare guidelines and expectations for that particular type of note, whether it's your start of care, your 30-day reassessments, and so on. Those need to be in compliance.

Set up a cadence of auditing, review it on a quarterly basis, and monitor it through your QAPI process. That would be my biggest suggestion for getting ahead of it this quarter. You've got to start now. You can't wait until the surveyor comes and finds everything. It's much better to be prepared in advance.

Sara Nigro · 43:44

Great question.

Next question: "Should we use ChatGPT for everything?" I'd love for you to elaborate.

Jamie Kuelker · 43:57

That gave me chest pain, if that tells you my answer.

Sara Nigro · 44:03

Yeah. I think with ChatGPT, we can't ignore AI and the role it's playing. But keep PHI out of it. That's my biggest stressor right now: making sure PHI stays out of AI. There are so many compliance risks there that you don't want to be exposed to. Putting in timestamps, theoretically, isn't a concern. But when you get to the medication for a specific patient and their name, yes, I'd say stay out of ChatGPT.

Jamie Kuelker · 44:38

Yeah, I would agree with that. HIPAA is HIPAA. It gives my clinician heart chest pain to think about putting in anything even remotely close to PHI. But if you're trying to develop processes or workflows, or build an audit, yes, check it out. There may be some great prompts you can use to help build those things out. But when it comes to PHI, proceed with caution. Do not put PHI in there.

Sara Nigro · 45:07

That's well said, Jamie. If you're going through this and trying to create a process, it's a great resource. If your team is using it with no PHI, it's wonderful for creating a process and helping you think it through: here's what my agency does today, so what are the next steps to get this plan in place?

Jamie Kuelker · 45:33

Absolutely. I encourage it, actually. I think we should use those resources that way.

Sara Nigro · 45:38

Absolutely.

Jamie Kuelker · 45:38

And if that's still not a reliable resource, or if you're questioning the validity of the response from whatever LLM you're using, whether it's Claude, ChatGPT, Gemini, or any of those, know that there are companies out there that adhere to best practices and have a lot of this already built out, such as QAPIplus, where I work. We serve clients across the entire country, and we have a lot of things already pre-built for you that you can customize based on your agency's expectations. So there are also people resources.

Sara Nigro · 46:13

Always.

Jamie Kuelker · 46:15

Don't forget the people.

Sara Nigro · 46:16

Don't forget the people.

I'm going to go ahead and drop my email in the chat. Jamie, if you don't mind doing that as well. That way, if folks have questions they don't want to bring up on this call, they can send us an email. Again, no judgment. We just want to help understand your workflows and what makes the most sense for your agency.

Jamie Kuelker · 46:44

I can type. I'll send it to everybody.

Sara Nigro · 46:46

Yeah. There we go. Thank you.

Jamie Kuelker · 46:51

Thank you.

Sara Nigro · 46:52

I think Austin just chimed in with a question: "If the IDG decides a medication is unrelated, how detailed does the rationale need to be?"

Jamie Kuelker · 47:03

I would say, if the medication is unrelated, do we really need to be ordering it? At that point, it's a question for deprescribing. Is it the right medication for this patient at this time? That's where I'd push back a bit and make sure you're actually assessing the necessity for that patient.

Sara Nigro · 47:24

All right. That's a good one. Thanks for chiming that one in.

Thank you all so much for joining us today. Again, feel free to reach out if you have any questions. We're going to be sending a copy of this webinar out. There was also a request for some one-pagers, which I think is brilliant. If there's anything specific your team wants to keep and print out at your agency, we're happy to send those over as well. Just send us a note. Otherwise, we'll let you all go. Have a great day, and thank you again. Thanks, Jamie.

Jamie Kuelker · 47:59

Thank you, Sara. It was great to have everyone. Have a good day. Happy Thanksgiving. Bye.